Opinion

Video

Optimizing Overall Health During CLL Management

Author(s):

Yuliya P.L Linhares, MD,Josie Montegaard, MSN, AGPCNP-BC

Yuliya Linhares, MD, discusses how healthy lifestyle choices, such as diet and exercise, can play a valuable role in optimizing CLL treatment outcomes.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Video content above is prompted by the following question(s):

      • What questions or concerns do patients have when starting treatment for chronic lymphocytic leukemia (CLL)? How might treatment affect their daily activities?
      • When and how are patients with CLL monitored?
      • How do you counsel patients about living with a chronic cancer like CLL and the potential need to remain on treatment?

      Newsletter

      Stay up to date on cancer updates, research and education

      Subscribe Now!
      Related Videos
      A variant in the IL-7 gene may predict which patients with kidney cancer are more likely to experience side effects from immunotherapy.
      Gene Variant May Predict Side Effects From Kidney Cancer Immunotherapy
      Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
      Breaking Down The Use of Rina-S in Advanced Ovarian Cancer
      Dr. Emre Yekedüz highlighted strategies that may improve patients' quality of life and mitigate treatment-related side effects in renal cell carcinoma.
      Investigating Quality of Life and Treatment Adherence in Kidney Cancer
      .Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
      Personalized Cancer Vaccine Demonstrates Responses in Kidney Cancer
      Dr. Catherine Wu is chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston, Massachusetts.
      Personalized Kidney Cancer Vaccine May Help Prevent Future Relapse
      Image of man with brown hair.
      ‘The Future Is Bright’ for R/R CLL Treatment Landscape
      Image of a man wearing a black button-up shirt.
      Understanding Treatment Sequences in Managing R/R CLL
      The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration
      The Future of CLL Care: Medical Breakthroughs and Patient-Physician Collaboration
      Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors
      Living Well With CLL: Nutrition, Exercise, and Lifestyle Tips From Patients and Doctors
      Fixed-Duration vs Continuous CLL Therapy: Balancing Efficacy, Quality of Life, and Costs
      Fixed-Duration vs Continuous CLL Therapy: Balancing Efficacy, Quality of Life, and Costs
      Related Content
      After surviving prostate cancer, Andy Winnegar received a diagnosis of chronic lymphocytic leukemia (CLL) in 2021. Catch up on Andy's blogs here!
      May 28th 2025

      Rebuilding Resilience: Navigating Aging and Exercise After CLL

      Andy Winnegar
      After running the Boston Marathon at 67, I faced new limits from aging and chronic lymphocytic leukemia — but I’ve found ways to stay strong and resilient.
      A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
      January 22nd 2024

      A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More

      Alex Biese Brielle Benyon
      We take a look at the first FDA approval in the oncology space for 2024, the Lymphedema Treatment Act and more.
      Chester Freeman was diagnosed with bladder cancer and most recently with chronic lymphocytic leukemia (CLL). Read more of Chester's blogs here!
      May 15th 2025

      Finding Comfort in Teddy Bears Throughout My Experience With CLL

      Chester Freeman
      As a patient with CLL, I’ve found comfort in teddy bears — first as a chaplain offering solace, now as a patient embracing their quiet presence myself.
      CURE Talks Cancer podcast
      December 31st 2020

      The Treatment Journey of a Patient with CLL

      Kristie L. Kahl
      In this episode of the “CURE Talks Cancer” podcast, we spoke with Mark Hoffman, a patient with chronic lymphocytic leukemia, about his diagnosis and treatment journey.
      The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for various cancers: © stock.adobe.com.
      May 6th 2025

      First Patient With Advanced Lung Cancer Dosed With Peluntamig Combo

      Spencer Feldman
      The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer and neuroendocrine carcinomas.
      An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy: © LukaszDesign - stock.adobe.com
      May 5th 2025

      AI Tool Predicts Pediatric Glioma Recurrence With Up to 89% Accuracy

      Spencer Feldman
      An AI model using serial brain scans predicted glioma recurrence in children with up to 89% accuracy, outperforming single-image methods.